{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:23:30Z","timestamp":1786980210294,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum Genet"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1007\/s004390000415","type":"journal-article","created":{"date-parts":[[2003,2,13]],"date-time":"2003-02-13T00:27:25Z","timestamp":1045096045000},"page":"612-614","source":"Crossref","is-referenced-by-count":43,"title":["Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda"],"prefix":"10.1007","volume":"107","author":[{"given":"L.","family":"Christiansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bygum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Brandrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"H\u00f8rder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. E.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"415_CR1","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/hep.510270627","volume":"27","author":"HL Bonkovsky","year":"1998","unstructured":"Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C, Tortorelli K, LeClair P, Mercurio MG, Lambrecht RW (1998) Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology 27: 1661\u20131669","journal-title":"Hepatology"},{"key":"415_CR2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF00196856","volume":"47","author":"A Catteau","year":"1995","unstructured":"Catteau A, Bechtel YC, Poisson N, Bechtel PR, Bonaiti-Pellie C (1995) A population and family study of CYP1A2 using caffeine urinary metabolites. Eur J Clin Pharmacol 47: 423\u2013430","journal-title":"Eur J Clin Pharmacol"},{"key":"415_CR3","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/clinchem\/45.11.2025","volume":"45","author":"L Christiansen","year":"1999","unstructured":"Christiansen L, Bygum A, Thomsen K, Brandrup F, Horder M, Petersen NE (1999) Denaturing gradient gel electrophoresis analysis of the hemochromatosis (HFE) gene: impact of HFE gene mutations on the manifestation of porphyria cutanea tarda. Clin Chem 45: 2025\u20132026","journal-title":"Clin Chem"},{"key":"415_CR4","doi-asserted-by":"crossref","unstructured":"Christiansen L, Bygum A, Jensen A, Brandrup F, Thomsen K, H\u00f8rder M, Petersen NE (2000) Uroporphyrinogen decarboxylase gene mutations in Danish patients with porphyria cutanea tarda. Scand J Clin Lab Invest (in press)","DOI":"10.1080\/003655100448365"},{"key":"415_CR5","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1046\/j.1523-1747.1998.00400.x","volume":"111","author":"M D\u2019Amato","year":"1998","unstructured":"D\u2019Amato M, Macri A, Griso D, Biolcati G, Ameglio F (1998) Are His63Asp or Cys282Tyr HFE mutations associated with porphyria cutanea tarda? Data of patients from central and southern Italy. J Invest Dermatol 111: 1241\u20131242","journal-title":"J Invest Dermatol"},{"key":"415_CR6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/bj2500161","volume":"250","author":"F Matteis De","year":"1988","unstructured":"De Matteis F, Harvey C, Reed C, Hempenius R (1988) Increased oxidation of uroporphyrinogen by an inducible liver microsomal system. Possible relevance to drug-induced uroporphyria. Biochem J 250: 161\u2013169","journal-title":"Biochem J"},{"key":"415_CR7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00008571-199510000-00001","volume":"5","author":"DL Eaton","year":"1995","unstructured":"Eaton DL, Gallagher EP, Bammler TK, Kunze KL (1995) Role of cytochrome P4501A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity. Pharmacogenetics 5: 259\u2013274","journal-title":"Pharmacogenetics"},{"key":"415_CR8","first-page":"55","volume-title":"Recent advances in dermatology","author":"GH Elder","year":"1990","unstructured":"Elder GH (1990) Porphyria cutanea tarda: a multifactorial disease. In: Champion RH, Rye RJ (eds) Recent advances in dermatology. Churchill Livingstone, Edingburgh, pp 55\u201369"},{"key":"415_CR9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF02110035","volume":"27","author":"GH Elder","year":"1995","unstructured":"Elder GH, Roberts AG (1995) Uroporphyrinogen decarboxylase. J Bioenerg Biomembr 27: 207\u2013214","journal-title":"J Bioenerg Biomembr"},{"key":"415_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-291X(87)90683-8","volume":"146","author":"JE Francis","year":"1987","unstructured":"Francis JE, Smith AG (1987) Polycyclic aromatic hydrocarbons cause hepatic porphyria in iron-loaded C57BL\/10 mice: comparison of uroporphyrinogen decarboxylase inhibition with induction of alkoxyphenoxazone dealkylations. Biochem Biophys Res Commun 146: 13\u201320","journal-title":"Biochem Biophys Res Commun"},{"key":"415_CR11","first-page":"604","volume":"90","author":"HA Jackson","year":"1999","unstructured":"Jackson HA, Whatley SD, Roberts AG, Morgan RR, Worwood M, Elder GH (1999) Haemochromatosis gene mutations in familial and sporadic porphyria cutanea tarda. Blood 90: 604","journal-title":"Blood"},{"key":"415_CR12","first-page":"2103","volume-title":"The metabolic basis of inherited diseases","author":"A Kappas","year":"1995","unstructured":"Kappas A, Sassa S, Galbraith RA, Nordmann Y (1995) The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited diseases, 7th edn. McGraw-Hill, New York, pp 2103\u20132160","edition":"7th edn."},{"key":"415_CR13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/bj2690437","volume":"269","author":"RW Lambrecht","year":"1990","unstructured":"Lambrecht RW, Jacobs JM, Sinclair PR, Sinclair JF (1990) Inhibition of uroporphyrinogen decarboxylase activity. The role of cytochrome P-450-mediated uroporphyrinogen oxidation. Biochem J 269: 437\u2013441","journal-title":"Biochem J"},{"key":"415_CR14","first-page":"396","volume":"39","author":"SL MacLeod","year":"1998","unstructured":"MacLeod SL, Tang Y-M, Yokoi, T., Kamataki, T., Doublin S, Lawson B, Massengill J, Kadlubar FF, Lang NP (1998) The role of a recently discovered genetic polymorphism in the regulation of the human CYP1A2 gene. Proc Am Assoc Cancer Res 39: 396\u2013396","journal-title":"Proc Am Assoc Cancer Res"},{"key":"415_CR15","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1086\/302119","volume":"63","author":"M Mendez","year":"1998","unstructured":"Mendez M, Sorkin L, Rossetti MV, Astrin KH, Del CBA, Parera VE, Aizencang G, Desnick RJ (1998) Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles. Am J Hum Genet 63: 1363\u20131375","journal-title":"Am J Hum Genet"},{"key":"415_CR16","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215","journal-title":"Nucleic Acids Res"},{"key":"415_CR17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/oxfordjournals.jbchem.a022352","volume":"125","author":"M Nakajima","year":"1999","unstructured":"Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M, Kamataki T (1999) Genetic polymorphism in the 5\u2032-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J Biochem (Tokyo) 125: 803\u2013808","journal-title":"J Biochem (Tokyo)"},{"key":"415_CR18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(96)09436-6","volume":"349","author":"AG Roberts","year":"1997","unstructured":"Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH (1997) Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda [see comments]. Lancet 349: 321\u2013323","journal-title":"Lancet"},{"key":"415_CR19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2125.1999.00898.x","volume":"47","author":"C Sachse","year":"1999","unstructured":"Sachse C, Brockmoller J, Bauer S, Roots I (1999) Functional significance of a C\u2192A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 47: 445\u2013449","journal-title":"Br J Clin Pharmacol"},{"key":"415_CR20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hep.510270128","volume":"27","author":"M Sampietro","year":"1998","unstructured":"Sampietro M, Piperno A, Lupica L, Arosio C, Vergani A, Corbetta N, Malosio I, Mattioli M, Fracanzani AL, Cappellini MD, Fiorelli G, Fargion S (1998) High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda [see comments]. Hepatology 27: 181\u2013184","journal-title":"Hepatology"},{"key":"415_CR21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/bj2480229","volume":"248","author":"SI Shedlofsky","year":"1987","unstructured":"Shedlofsky SI, Sinclair PR, Bonkovsky HL, Healey JF, Swim AT, Robinson JM (1987) Haem synthesis from exogenous 5aminolaevulinate in cultured chickembryo hepatocytes. Effects of inducers of cytochromes P-450. Biochem J 248: 229\u2013236","journal-title":"Biochem J"},{"key":"415_CR22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0168-8278(95)80004-2","volume":"23","author":"PD Siersema","year":"1995","unstructured":"Siersema PD, Rademakers LH, Cleton MI, ten Kate FJ, de Bruijn WC, Marx JJ, Wilson JH (1995) The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron. J Hepatol 23: 259\u2013267","journal-title":"J Hepatol"},{"key":"415_CR23","first-page":"1019","volume":"26","author":"PR Sinclair","year":"1998","unstructured":"Sinclair PR, Gorman N, Tsyrlov IB, Fuhr U, Walton HS, Sinclair JF (1998a) Uroporphyrinogen oxidation catalyzed by human cytochromes P450. Drug Metab Dispos 26: 1019\u20131025","journal-title":"Drug Metab Dispos"},{"key":"415_CR24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1042\/bj3300149","volume":"330","author":"PR Sinclair","year":"1998","unstructured":"Sinclair PR, Gorman N, Dalton T, Walton HS, Bement WJ, Sinclair JF, Smith AG, Nebert DW (1998b) Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cypla2(-\/-) null mutant mice. Biochem J 330: 149\u2013153","journal-title":"Biochem J"},{"key":"415_CR25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/taap.1999.8832","volume":"162","author":"PR Sinclair","year":"2000","unstructured":"Sinclair PR, Gorman N, Walton HS, Bement WJ, Dalton TP, Sinclair JF, Smith AG, Nebert DW (2000) CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron. Toxicol Appl Pharmacol 162: 60\u201367","journal-title":"Toxicol Appl Pharmacol"},{"key":"415_CR26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1042\/bj2460221","volume":"246","author":"AG Smith","year":"1987","unstructured":"Smith AG, Francis JE (1987) Chemically-induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with iron overload. Biochem J 246: 221\u2013226","journal-title":"Biochem J"},{"key":"415_CR27","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0168-8278(98)80313-9","volume":"28","author":"KA Stuart","year":"1998","unstructured":"Stuart KA, Busfield F, Jazwinska EC, Gibson P, Butterworth LA, Cooksley WG, Powell LW, Crawford DH (1998) The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients. J Hepatol 28: 404\u2013409","journal-title":"J Hepatol"},{"key":"415_CR28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1042\/bj2530357","volume":"253","author":"AJ Urquhart","year":"1988","unstructured":"Urquhart AJ, Elder GH, Roberts AG, Lambrecht RW, Sinclair PR, Bement WJ, Gorman N, Sinclair JA (1988) Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acid. Biochem J 253: 357\u201336","journal-title":"Biochem J"}],"container-title":["Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s004390000415.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s004390000415\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s004390000415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T16:25:18Z","timestamp":1682439918000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s004390000415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["415"],"URL":"https:\/\/doi.org\/10.1007\/s004390000415","relation":{},"ISSN":["0340-6717","1432-1203"],"issn-type":[{"value":"0340-6717","type":"print"},{"value":"1432-1203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}